Ventyx Biosciences, Inc. has raised $27.0M in total funding. The most recent round was Series B.
Ventyx Biosciences, Inc. is headquartered in San Diego, CA.
The Encinitas-based clinical-stage biotech was acquired by Eli Lilly for $1.2 billion in cash, after IPOing on Nasdaq (VTYX) in 2021.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.